Stereotaxis Corporation (STXS) Enterprise Value to EBITDA Ratio
Stereotaxis, Inc. (STXS) develops robotic systems for catheter ablation, ensuring physician safety within the arrhythmia treatment segment. The historical price action based on the EV/EBITDA multiple is currently at 0.00. High business scalability is achieved through the sale of software and disposable instruments. The installed equipment base guarantees a regular inflow of funds, turning the supply of consumables into a stable cash cow.
Comprehensive metric breakdowns and analytics for stereotaxis.com (STXS)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
STXS - Net Financial Result|Projected Future Earnings Stereotaxis, Inc.|STXS - Price to Earnings Ratio|Forward P/E Multiple Stereotaxis, Inc.|STXS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis Corporation|STXS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Stereotaxis|STXS - Earnings per share for the trailing year|Quarterly EPS earnings growth stereotaxis.com|STXS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Stereotaxis, Inc.
Analysis of all company metrics:Stereotaxis Corp STXS
Investors must eliminate speculative risks by assessing the real value of Stereotaxis, Inc. (STXS) assets. Current deliveries of Genesis systems establish an operational base, yet full-scale growth is expected following the launch of new catheters. Evaluating the business via EV/EBITDA trends compares the company's total enterprise value, including debt and taxes, against its operating profit. This indicator determines whether the asset is overvalued relative to its ability to generate cash flow.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|ReWalk Robotics Ltd. (LFWD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AMIX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio IVF|BBLG (Bone Biologics Corp.) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXNX|BIOL - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dynatronics DYNT|Business Value to Operating Income Before Depreciation FNA|INVO Bio - EV/EBITDA Multiple
